NEW YORK, Sept. 16, 2019 -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Fibrocell Science, Inc..
NEW YORK, NY / ACCESSWIRE / October 18, 2019 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Vitamin Shoppe, Inc. (NYSE:VSI) The investigation concerns ...
NEW YORK, Oct. 22, 2019 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Roan Resources, Inc. (NYSE: ROAN)The.
NEW YORK , Sept. 18, 2019 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York ...
WILMINGTON, Del., Sept. 19, 2019 -- Rigrodsky & Long, P.A. announces that it is investigating: SemGroup Corporation (NYSE: SEMG) regarding possible breaches of fiduciary.
NEW YORK, Nov. 01, 2019 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Fibrocell Science, Inc. (NASDAQ: FCSC)The.
NEW YORK , Oct. 25, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Fibrocell Science, Inc. ("FCSC" or the ...
Timken Company (NYSE: TKR ), a power transmission products company, announced it has reached an agreement to acquire BEKA Lubrication, a supplier of automatic lubrication systems for $165 million. BEKA is ...
NEW YORK , Sept. 17, 2019 /PRNewswire/ -- Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Fibrocell Science, Inc. (NASDAQ: FCSC) on behalf of Fibrocell shareholders ...
NEW YORK, NY / ACCESSWIRE / October 15, 2019 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) The investigation ...
The investigation concerns whether United Community and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of United Community to First Defiance Financial Corp. Under the terms of the agreement, United Community shareholders will receive 0.3715 shares of First Defiance common stock for each share of United Community common stock. If you are a United Community shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/united-community-financial-corp-ucfc-first-defiance-merger-stock/.
NEW YORK, Oct. 15, 2019 -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of SRC Energy Inc. (NYSE:.
BALA CYNWYD, PA / ACCESSWIRE / October 28, 2019 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Fibrocell Science, Inc. ("Fibrocell" ...
Reata (RETA) rallies following the successful completion of a pivotal study evaluating omaveloxolone as a potential treatment for Friedreich's ataxia, a progressive neuromuscular disorder.
WILMINGTON, Del., Oct. 17, 2019 -- Rigrodsky & Long, P.A. announces that it is investigating: Ra Pharmaceuticals, Inc. (NASDAQ GS: RARX) regarding possible breaches of.
NEW YORK , Oct. 8, 2019 /PRNewswire/ -- Church & Dwight Co. (CHD) Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations of "significant ...
WILMINGTON, DE / ACCESSWIRE / September 16, 2019 / Rigrodsky & Long, P.A.: Do you own shares of Fibrocell Science, Inc. (NASDAQ GS: FCSC )? Did you purchase any of your shares prior to September 12, 2019? ...
Castle Creek Pharmaceutical Holdings announced it will acquire Fibrocell Science, Inc. (NASDAQ: FCSC ), a cell and gene therapy company in a $3 per share cash. Castle Creek Pharmaceuticals is a privately ...
The buyer and seller are both developing potential therapies for a rare genetic skin condition that afflicts 'butterfly children.'
NEW YORK, Oct. 15, 2019 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Proteon Therapeutics, Inc. (NASDAQ: PRTO)The.